Predictive Value of Serial Multiparametric MRI and FDG-PET/CT in Head and Neck Cancer

Overview

This study evaluated the utility of serial diffusion-weighted MRI (DWI) and FDG-PET/CT imaging during radiotherapy to predict treatment outcomes in head and neck squamous cell carcinoma. The findings suggest that mid-treatment changes in these imaging biomarkers can serve as early predictors of local tumor recurrence, potentially guiding personalized treatment adaptations.

Background

Locally advanced mucosal head and neck squamous cell carcinoma is commonly treated with definitive radiotherapy, often combined with systemic therapy, aiming for organ preservation. Despite treatment, a significant proportion of patients experience locoregional recurrence, which leads to morbidity and mortality. Traditional prognostic markers such as TNM stage, smoking history, and HPV status provide limited predictive value for treatment response. Functional imaging modalities like DWI MRI and FDG-PET/CT offer non-invasive, quantitative assessments of tumor biology and have shown promise as early surrogate markers of treatment response when performed serially during therapy.

Data Highlights

Patients underwent serial multiparametric MRI (DWI, T2) before, during (weeks 2, 3, 5, 6), and after radiotherapy, and FDG-PET/CT before and at week 3 of treatment. Imaging parameters analyzed included ADCmean from DWI and metabolic tumor volume (MTV), SUVmax, SUVmean, and total lesion glycolysis (TLG) from FDG-PET/CT. Percentage changes from baseline were calculated for each parameter at each time point. Treatment response was assessed by 1-year local, regional, and distant recurrence rates and death.

Key Findings

• Mid-treatment changes in DWI and FDG-PET/CT parameters provide complementary biological information predictive of treatment response.
• Changes in ADCmean during radiotherapy correlated with local tumor control, with specific time points (weeks 2-3) identified as optimal for assessment.
• FDG-PET/CT parameters such as MTV and TLG showed significant changes at week 3 that were associated with treatment outcomes.
• Pre-treatment imaging alone was less predictive of response compared to serial imaging during therapy.
• Combining multiparametric MRI and FDG-PET/CT improved the accuracy of predicting local recurrence compared to single modality imaging.

Clinical Implications

Serial functional imaging during radiotherapy can identify early tumor response, enabling clinicians to tailor treatment intensity. Optimal timing for imaging assessment appears to be around weeks 2 to 3 of therapy, which may inform decisions on treatment adaptation. Incorporating multiparametric MRI and FDG-PET/CT into routine monitoring could improve prognostication and potentially reduce unnecessary toxicity by guiding de-intensification in responders.

Conclusion

Serial multiparametric MRI and FDG-PET/CT imaging during radiotherapy offer valuable predictive biomarkers for treatment outcomes in head and neck cancer. Early changes in these imaging parameters can guide personalized treatment strategies to improve local control and reduce morbidity.

References

1. Author/Source/Year -- Predictive Value of Serial Multiparametric MRI and FDG-PET/CT Imaging Changes During Radiation Therapy for Treatment Outcomes in Head and Neck Cancer Patients